Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
239.1400
-3.23
(
-1.33
%)
NSE
Jun 04, 2026
15:31 PM
54.28% Gain from 52W Low
Volume:
1.5M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
14 Mar 2024
239.14
-1.33%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 301
Target
Ventura
Growth in demand and capabilities
Institutional Investors have increased holdings from 14.04% to 23.33% in Mar 2026 qtr.
More from Marksans Pharma Ltd.
Recommended
Market closes flat amid weakness in IT stocks and uncertainty over the US-Iran peace deal
Trendlyne Marketwatch |
04 Jun 2026, 04:01PM
Is a dual threat coming for the Indian economy?
The Baseline |
04 Jun 2026, 12:11PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017